Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30019458HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019459HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30085139HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023974HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023975HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023976HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023977HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20042586HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20027367HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20034731HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB16756
Drug NameIvarmacitinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs34374027
CitationsZhao Y, Zhang L, Ding Y, Tao X, Ji C, Dong X, Lu J, Wu L, Wang R, Lu Q, Goh AH, Liu R, Zhang Z, Zhang J: Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial. Am J Clin Dermatol. 2021 Nov;22(6):877-889. doi: 10.1007/s40257-021-00627-2. Epub 2021 Aug 9.
GroupsExperimental; Investigational
Direct Classification
SMILES[H][C@@]12C[C@H](C[C@]1([H])CN(C2)C(=O)NC1=NC(OC)=NS1)N(C)C1=NC=NC2=C1C=CN2
Pathways
PharmGKB
ChEMBL